{"id":31617,"date":"2022-11-09T19:49:10","date_gmt":"2022-11-09T14:49:10","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=101964"},"modified":"2022-11-09T19:49:10","modified_gmt":"2022-11-09T14:49:10","slug":"citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk","status":"publish","type":"post","link":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/","title":{"rendered":"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK"},"content":{"rendered":"

New alliance will boost access\u00a0to clinical trials\u00a0for thousands of individuals in the UK through their clinicians<\/h4>\n

NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — EMIS, the leading provider of healthcare software, information technology and related services in the UK, and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, today announced a strategic partnership to make clinical trials more accessible to patient populations throughout the UK.<\/p>\n

This relationship will allow EMIS to better serve its communities by providing direct, immediate opportunities for eligible patients to participate in clinical trials. EMIS Group\u2019s Recruit product will notify clinicians when new opportunities arise for their patients to consider and enroll in clinical trials as a care option. EMIS Recruit uses advanced analytics and algorithms powered by EMIS-X to identify eligible patients.<\/p>\n

\u201cWe are excited at this tremendous opportunity to open clinical research opportunities to patients throughout the UK and support clinical trial diversity efforts,\u201d said Suzy Foster, CEO of EMIS Health and EMIS Enterprise. \u201cThis innovative collaboration between EMIS Group and Citeline Connect has potential to change patients\u2019 lives and advance healthcare.\u201d<\/p>\n

Citeline Connect is a comprehensive platform and marketplace that powers smarter, simpler patient referrals for clinical trials with HIPAA, GDPR-compliant technology. It enables clinical trial sponsors to securely share recruitment opportunities with a vetted network of patient recruitment companies, healthcare organizations, and patient advocacy groups. Citeline Connect bridges the gap between Citeline-coordinated clinical trials in search of patients and healthcare organizations with patients looking for promising potential solutions for the management of their conditions.<\/p>\n

\u201cEMIS\u2019s infrastructure underpins most of the UK health system, and their reach into healthcare professionals and patients throughout the UK is unmatched,\u201d says Ashley Schwalje, Head of Commercialization at Citeline Connect. \u201cSpeaking on behalf of the entire leadership team at Citeline, we couldn\u2019t be more thrilled to welcome EMIS into the Citeline Connect community.\u201d<\/p>\n

About EMIS<\/strong><\/p>\n

EMIS is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS\u2019s aim is to be the leading provider of innovative healthcare technology that improves people\u2019s lives. This helps healthcare professionals to deliver better, more efficient healthcare, supporting longer and healthier lives.<\/p>\n

EMIS has two core business segments: EMIS Health and EMIS Enterprise.<\/p>\n

About Citeline Connect<\/strong><\/p>\n

Citeline Connect is the most comprehensive solution for clinical trial engagement and recruitment. This solution revolutionizes how patients find and enroll in clinical research across the globe by combining the power of data-driven technology with the\u00a0reach of proprietary HCP networks and\u00a085+ pre-vetted partners from an industry-first patient referral collective. For more information, visit\u00a0CitelineConnect.com<\/a>.<\/p>\n

Media Contacts<\/strong><\/p>\n

EMIS Group<\/strong>
\nemis@weareic.com<\/a><\/p>\n

Citeline PR<\/strong>
\ncitelineuk@diffusionpr.com<\/a><\/p>\n

GlobeNewswire Distribution ID 8692356<\/p>\n","protected":false},"excerpt":{"rendered":"

New alliance will boost access\u00a0to clinical trials\u00a0for thousands of individuals in the UK through their clinicians NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) \u2014 EMIS, the leading provider of healthcare software, information technology and related services in the UK, and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, today announced a [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\nCiteline and EMIS Partner to Expand Clinical Trial Access in the UK - Myanmar News Gazette<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK - Myanmar News Gazette\" \/>\n<meta property=\"og:description\" content=\"New alliance will boost access\u00a0to clinical trials\u00a0for thousands of individuals in the UK through their clinicians NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) \u2014 EMIS, the leading provider of healthcare software, information technology and related services in the UK, and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, today announced a [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\" \/>\n<meta property=\"og:site_name\" content=\"Myanmar News Gazette\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-09T14:49:10+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f\"},\"headline\":\"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK\",\"datePublished\":\"2022-11-09T14:49:10+00:00\",\"dateModified\":\"2022-11-09T14:49:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\"},\"wordCount\":466,\"publisher\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\",\"url\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\",\"name\":\"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK - Myanmar News Gazette\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#website\"},\"datePublished\":\"2022-11-09T14:49:10+00:00\",\"dateModified\":\"2022-11-09T14:49:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/myanmarnewsgazette.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#website\",\"url\":\"https:\/\/myanmarnewsgazette.com\/\",\"name\":\"Myanmar News Gazette\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/myanmarnewsgazette.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#organization\",\"name\":\"Myanmar News Gazette\",\"url\":\"https:\/\/myanmarnewsgazette.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png\",\"contentUrl\":\"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png\",\"width\":200,\"height\":200,\"caption\":\"Myanmar News Gazette\"},\"image\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/myanmarnewsgazette.com\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK - Myanmar News Gazette","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/","og_locale":"en_US","og_type":"article","og_title":"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK - Myanmar News Gazette","og_description":"New alliance will boost access\u00a0to clinical trials\u00a0for thousands of individuals in the UK through their clinicians NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) \u2014 EMIS, the leading provider of healthcare software, information technology and related services in the UK, and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, today announced a [\u2026]","og_url":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/","og_site_name":"Myanmar News Gazette","article_published_time":"2022-11-09T14:49:10+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/#article","isPartOf":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/"},"author":{"name":"admin","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f"},"headline":"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK","datePublished":"2022-11-09T14:49:10+00:00","dateModified":"2022-11-09T14:49:10+00:00","mainEntityOfPage":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/"},"wordCount":466,"publisher":{"@id":"https:\/\/myanmarnewsgazette.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/","url":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/","name":"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK - Myanmar News Gazette","isPartOf":{"@id":"https:\/\/myanmarnewsgazette.com\/#website"},"datePublished":"2022-11-09T14:49:10+00:00","dateModified":"2022-11-09T14:49:10+00:00","breadcrumb":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/myanmarnewsgazette.com\/citeline-and-emis-partner-to-expand-clinical-trial-access-in-the-uk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/myanmarnewsgazette.com\/"},{"@type":"ListItem","position":2,"name":"Citeline and EMIS Partner to Expand Clinical Trial Access in the UK"}]},{"@type":"WebSite","@id":"https:\/\/myanmarnewsgazette.com\/#website","url":"https:\/\/myanmarnewsgazette.com\/","name":"Myanmar News Gazette","description":"","publisher":{"@id":"https:\/\/myanmarnewsgazette.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/myanmarnewsgazette.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/myanmarnewsgazette.com\/#organization","name":"Myanmar News Gazette","url":"https:\/\/myanmarnewsgazette.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/","url":"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png","contentUrl":"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png","width":200,"height":200,"caption":"Myanmar News Gazette"},"image":{"@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/myanmarnewsgazette.com\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/posts\/31617"}],"collection":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/comments?post=31617"}],"version-history":[{"count":0,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/posts\/31617\/revisions"}],"wp:attachment":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/media?parent=31617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/categories?post=31617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/tags?post=31617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}